TatyanaMilmanMD
Ophthalmology • Philadelphia, PAAssociate Professor, Ophthalmology, New York Medical College
Dr. Milman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
840 Walnut St Ste 1410
Philadelphia, PA 19107Phone+1 215-928-3280
Education & Training
Rutgers New Jersey Medical SchoolResidency, Ophthalmology, 2001 - 2004
Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 2000 - 2001
Perelman School of Medicine at the University of PennsylvaniaClass of 2000
Certifications & Licensure
CA State Medical License 2006 - Present
PA State Medical License 2000 - 2024
NJ State Medical License 2004 - 2017
NY State Medical License 2006 - 2017- American Board of Ophthalmology Ophthalmology
- American Board of Pathology Pathology - Anatomic
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 344 citationsCollaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal MelanomaMichael D. Onken, Lori A. Worley, Devron H. Char, James J. Augsburger, Zelia M. Correa
Ophthalmology. 2012-08-01 - 29 citationsDiagnostic utility of adipophilin immunostain in periocular carcinomas.Tatyana Milman, Matthew J. Schear, Ralph C. Eagle
Ophthalmology. 2014-04-01 - 36 citationsOcular manifestations of multiple myeloma: three cases and a review of the literature.Kimberly J. Chin, Sanford Kempin, Tatyana Milman, Paul T. Finger
Optometry. 2011-04-01
Journal Articles
- An Unusual Upper Eyelid MassTatyana Milman, MD, JAMA Ophthalmology
- An Unusual Upper Eyelid MassTatyana Milman, MD, JAMA Ophthalmology
Authored Content
- February 2024 Wills Eye Resident Case SeriesFebruary 2024
Press Mentions
Amydis to Present First Ocular Tracer Designed to Detect Transthyretin Amyloidosis (ATTR) at AAOOP ConferenceOctober 10th, 2024
2016 Pre-Meeting MaterialsMarch 11th, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
